Cafepharma Today

March 10 2025 - On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Novo Nordisk's Ozempic successor disappointed Wall Street again
AstraZeneca reports positive outcomes from trial of Imfinzi
The evolution of medical sales: what’s changing in 2025?
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche Financing For Genentech Deal Looks Tough
Pharmalot
Monday, December 1, 2008 - 8:14am
tags:
Cell Therapeutics receives FDA priority review for expanded use of cancer drug Zevalin
Yahoo/AP
Monday, December 1, 2008 - 8:02am
tags:
Vical receives $1 million payment for licensing deal on potential cancer drug with Merck
Yahoo/AP
Monday, December 1, 2008 - 8:02am
tags:
Latest Postmortem on Torcetrapib Leaves Hope for HDL Boosters
WSJ Online
Monday, December 1, 2008 - 7:35am
tags:
Lilly Drops Its Cymbalta Application
WSJ Online
Monday, December 1, 2008 - 7:34am
tags:
Teva Grabs Billions Gambling on Copies of Brand-Name Drugs
Bloomberg
Monday, December 1, 2008 - 7:33am
tags:
China Biotech in Review: Deals and Healthcare Stimulus
Seeking Alpha
Sunday, November 30, 2008 - 11:30am
tags:
Teva looks set to win German tender
Globes, Israel
Sunday, November 30, 2008 - 11:29am
tags:
Europe Accuses Drug Makers of Padding Health Care Costs
Ocala.com, FL
Sunday, November 30, 2008 - 11:26am
tags:
Cook's growth is still sizzling
Indianapolis Star, IN
Sunday, November 30, 2008 - 10:37am
tags:
Cell Therapeutics, Spectrum in deal to sell Zevalin
bizjournals
Sunday, November 30, 2008 - 10:27am
tags:
BioCryst named 29th fastest growing tech firm
bizjournals
Sunday, November 30, 2008 - 10:25am
tags:
ViroPharma adds 2nd drug
Bizjournals.com
Friday, November 28, 2008 - 10:17am
tags:
Analysts: Big Biotech will grow despite economy
Fierce Biotech
Friday, November 28, 2008 - 10:12am
tags:
IMPAX Receives Final FDA Approval for Generic Wellbutrin(R) XL 150 mg
Marketwatch
Friday, November 28, 2008 - 10:11am
tags:
From Patent Thickets to Payoffs: How Big Pharma Fights Generics
WSJ Online
Friday, November 28, 2008 - 9:59am
tags:
Novartis CEO sees higher dividend in future
Trading Markets
Friday, November 28, 2008 - 9:54am
tags:
RegeneRx: A Beaten Down Biotech
Seeking Alpha
Friday, November 28, 2008 - 9:53am
tags:
Enzon biotech sale under threat
In-PharmaTechnologist
Friday, November 28, 2008 - 9:52am
tags:
Lilly withdraws Cymbalta chronic pain application, plans to resubmit request in early 2009
Yahoo/AP
Friday, November 28, 2008 - 9:51am
tags:

Pages

Latest CP Wire Articles

The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform

Latest Pharmagather Articles

Bridging the Gap in Patient Support: How GoodRx is Revolutionizing Access to Specialty Meds
Drug Channels
Bird is the (Geomagnetic) Word
In the Pipeline
The Continuing Crisis, Part VII: An Overview
In the Pipeline
Transparency vs. Reality: Troubling Lessons from PBM Disclosure Laws
Drug Channels
The Continuing Crisis, Part VI: Rare Diseases at the FDA and More
In the Pipeline
PBM Industry Update: Trends, Challenges, and What's Ahead (NEW Live Video Webinar)
Drug Channels
Progress on RNA-Based Cancer Vaccines
In the Pipeline
Patient Care’s Next Big Shift: 80% of Leaders Say This Is the Game Changer
Drug Channels
Available for Preorder: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information